Delivery Order SPE2DR25D6028-SPE2DR26FAQVK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ketorolac 30 mg/mL in vial form, with a ceiling value of $1,339.14. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The order is scheduled for ultimate completion on September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Ketorolac 30 mg/mL vials with a ceiling value of $2,472.26. This firm fixed-price delivery order represents a non-competitive set-aside contract and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,115.75 for Ketorolac 30 mg/ml vials, with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999 ceiling value through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $2,424.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials. This delivery order was issued without a set-aside designation, indicating open competition, and carries an ultimate completion date of July 7, 2025. The award was issued on July 3, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,086.88 delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/ml vials under a firm fixed price contract type. The award was issued on July 11, 2025, with an ultimate completion date of July 14, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is a child contract under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ketorolac 30 mg/mL vials with a ceiling value of $1,002.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $1,163.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30 mg/mL vial supply on September 22, 2025, with completion targeted for September 23, 2025. This is a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transactional purchase under a larger contract vehicle supporting the federal government's...
- The Defense Logistics Agency awarded a $4,423.20 delivery order to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials on May 30, 2025, with completion scheduled for June 2, 2025. This competitively awarded contract utilizes a firm fixed price structure and is classified as a child contract under a larger vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ketorolac is a nonsteroidal anti-inflammatory drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.80 to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/ml vials. This competitive, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,194.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ketorolac 30 mg/ml vials. The contract is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAQVKDelivery Order
The Defense Logistics Agency awarded a $10,217.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ketorolac 30mg/ml (25 units) on October 22, 2025, with completion targeted for November 19, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. Ketorolac is a nonsteroidal anti-inflammatory drug commonly used for short-term pain management in military medical settings. This delivery order leverages AmerisourceBergen's established relationship as a prime pharmaceutical vendor under the DLA's global pharmaceutical support vehicle, which enables the company to supply medications and medical commodities to support military healthcare programs worldwide. The DLA Troop Support is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among a select group of qualified vendors serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 10/22/25 |